Metabolic Scarring: The Persistent Impact of Past Obesity on Long‐Term Metabolic Health Despite Weight Loss
Endocrinology, Diabetes & Metabolism · 2025
DOI: 10.1002/edm2.70086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, 2025. Verfasst von Ali Hemade und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Lebanese University, Hadat, Lebanon. Hauptthemen laut MEDLINE: Obesity, Weight Loss. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Conventional cardiometabolic risk assessment relies primarily on a patient's current body mass index, yet individuals who have lost weight after a period of obesity may continue to harbour elevated metabolic risk. We sought to quantify the persistent impact of past obesity on glycaemic control and to develop a clinical risk score that integrates weight history with current risk factors.
Methods
We performed a cross‐sectional analysis of 15,422 adults (≥ 18 years) from the 2011–2020 NHANES cycles. Participants with complete self‐reported weight history (highest adult weight, weight 1 year ago, number of ≥ 5% weight‐loss episodes) and measured BMI were included. Metabolic scarring was defined by elevated haemoglobin A1c (HbA1c ≥ 5.7%) or HOMA‐IR ≥ 2.5. We applied inverse‐probability‐weighted logistic regression to estimate the association between prior obesity and current HbA1c, adjusting for confounders. We then refit a survey‐weighted logistic model using age per decade, current BMI, weight‐history category, sex and race/ethnicity, converting regression coefficients into an integer point‐based score. Discrimination was evaluated by survey‐weighted area under the receiver‐operating characteristic curve (AUC).
Results
Formerly obese individuals exhibited significantly higher HbA1c than never‐obese peers (adjusted β = 0.58%, p < 0.002), indicative of metabolic scarring. The derived risk score ranged from −31 to +90 points (median = 6; IQR = −3 to 16) and achieved an AUC of 0.79 (95% CI 0.77–0.81). Age per decade, BMI, and weight history contributed 4, 1 and up to 4 points, respectively; female sex and Non‐Hispanic White race subtracted points. Calibration across predicted‐risk deciles was excellent (slope = 0.98).
Conclusions
A history of obesity imparts a lasting glycemic risk that is not captured by current BMI alone. Our metabolic scarring risk score offers a pragmatic tool for identifying individuals at elevated metabolic risk despite weight normalisation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Lebanese University, Hadat, Lebanon.
- Faculty of Pharmacy, Lebanese University, Hadat, Lebanon.
- Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon.
- Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus.
- Institut National de Santé Publique d'Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon.
ORCID-Profile: Ali Hemade, Pascale Salameh
Zitieren
APA
Hemade, A., & Salameh, P. (2025). Metabolic Scarring: The Persistent Impact of Past Obesity on Long‐Term Metabolic Health Despite Weight Loss. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.70086
Vancouver
Hemade A, Salameh P. Metabolic Scarring: The Persistent Impact of Past Obesity on Long‐Term Metabolic Health Despite Weight Loss. Endocrinology, Diabetes & Metabolism. 2025. doi:10.1002/edm2.70086
BibTeX
@article{Hemade2025,
author = {Hemade, Ali and Salameh, Pascale},
title = {Metabolic Scarring: The Persistent Impact of Past Obesity on Long‐Term Metabolic Health Despite Weight Loss},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2025},
doi = {10.1002/edm2.70086}
}
EUVIMED